Next Article in Journal
Statins in Children with Neurofibromatosis Type 1: A Systematic Review of Randomized Controlled Trials
Previous Article in Journal
The Impact of COVID-19 on Multidisciplinary Care Delivery to Children with Cerebral Palsy and Other Neuromuscular Complex Chronic Conditions
Previous Article in Special Issue
Meticulous and Early Understanding of Congenital Cranial Defects Can Save Lives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Idiopathic Slipped Capital Femoral Epiphysis: Demographic Differences and Similarities between Stable, Unstable, and Valgus Types

Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA
*
Author to whom correspondence should be addressed.
Children 2023, 10(9), 1557; https://doi.org/10.3390/children10091557
Submission received: 25 July 2023 / Revised: 15 August 2023 / Accepted: 13 September 2023 / Published: 15 September 2023
(This article belongs to the Special Issue Bone Development and Disease in Infants (Volume II))

Abstract

:
Idiopathic slipped capital femoral epiphysis (SCFE) is a known disorder in pre/adolescent children with vague hip/knee pain. We wished to study the demographic differences between stable varus, unstable varus, and valgus idiopathic SCFEs using a retrospective review over a 10-year period of SCFE children seen at a tertiary children’s hospital. Standard demographic data was collected, and radiographs were measured to determine the Southwick angle and status of the tri-radiate cartilage. There were 190 patients; 138 had stable varus SCFEs, 45 unstable varus SCFEs, and 7 valgus SCFEs. All unstable SCFEs were varus, and all valgus SCFEs were stable. There were significant differences between the three groups by age at diagnosis, sex, race, SCFE severity, weight percentile, and duration of symptoms. The average age at diagnosis was 11.0 ± 1.2, 11.8 ± 1.8, and 12.3 ± 1.7 years for the valgus, unstable varus, and stable varus groups (p = 0.019), and similarly, SCFE severity was 25° ± 15°, 48° ± 18°, and 35° ± 19° (p = 0.0002) for the three same groups. Patients with valgus SCFEs were mostly female (86%) compared to the stable varus (39.9%) and unstable (47%) groups (p = 0.05) and mostly non-White (86%) (0.011). The duration of symptoms was 4.1 ± 4.1, 2.3 ± 5.0, and 4.5 ± 5.0 months for the valgus, unstable varus, and stable varus groups (p = 0.00005). These three types of idiopathic SCFEs demonstrated differences by age at diagnosis, sex, race, weight percentile, and duration of symptoms.

1. Introduction

Slipped capital femoral epiphysis (SCFE) can be divided into idiopathic and atypical types [1,2], with idiopathic being more common [1]. Most SCFEs demonstrate a varus deformity, although valgus types do exist [3,4,5]. The typical SCFE demonstrates an inferior displacement of the epiphysis relative to the metaphysis on radiographs, thus a varus deformity; however, a few may demonstrate a superior displacement of the epiphysis relative to the metaphysis on radiographs, or a valgus deformity. Similarly, they are either stable or unstable [6]. A stable SCFE is where the child can ambulate with or without crutches; an unstable SCFE is when the child can not ambulate, with or without crutches. [6].
The general demographics of SCFE have been relatively well studied [7,8,9,10,11,12,13,14,15,16,17,18,19]. There is a slight male predominance, with the most recent series in the 60% range for boys. The average age of presentation in modern-day children is 12 years for boys and 11 years for girls, but in studies from the early 1900s was 15 years [14]; the average symptom duration is 4 to 5 months. SCFE is relatively more common in Polynesian, Black, and Hispanic children compared to White children, and quite rare in those of Indian subcontinent descent [17]. Most of the children are overweight and/or obese. The vast majority of the SCFEs are the stable type. However, there are no studies comparing the demographics between all three types of idiopathic SCFEs—stable varus, unstable varus, and valgus. It was the purpose of this study to explore this area and see if differences exist in demographic variables between these three types of idiopathic SCFEs.

2. Materials and Methods

This is an observational study of all patients with SCFE treated at a tertiary children’s hospital for the time period January 2010 through March 2021. The medical records and radiographs were reviewed to confirm the diagnosis. Inclusion criteria were any patient with an idiopathic SCFE, excluding all non-idiopathic types. For patients with bilateral SCFEs, the data for the first hip was used for those with sequential presentation, and for those with bilateral simultaneous presentation, the hip having the longest duration of symptoms was used. The demographic data that was collected for this patient cohort was the child’s chronologic age, duration of symptoms, the height and weight of the patient at the time of diagnosis, and the child’s sex and race. For each of the SCFEs, the laterality (unilateral right or left, unilateral, sequential bilateral, and simultaneous bilateral). The stable/unstable nature of the SCFE [6] was determined from the medical records. The patient’s race was categorized as White or non-White. The lateral epiphyseal-shaft angle (LESA), as described by Southwick [20], was used to measure the severity of the SCFE. The SCFEs were designated as mild (<30° LESA), moderate (30–50° LESA), or severe (>50° LESA) [21]. The tri-radiate cartilage status at diagnosis of the first SCFE was graded as open, closing, or closed, as described by Acheson [22]. The senior author, with a long-standing interest in SCFE, reviewed the radiographs, performed the angular measurements, and determined the valgus/varus nature of the SCFE. The child’s height and weight were converted to percentiles using online growth charts from the CDC. This was performed using the SimulConsult app (https://simulconsult.com/resources/measurement.html?type=weight, accessed on 6 June 2021). The body mass index (BMI) (kg/m2) and percentile of the patient were calculated using the Baylor College of Medicine app (https://www.bcm.edu/cnrc-apps/bodycomp/bmiz2.html, accessed on 6 June 2021). Our local Institutional Review Board had approved the study.
Systat 10™ software was used to perform statistical analyses. Continuous variables are expressed as the average ± 1 standard deviation. Categorical variables are expressed as percentages and frequencies. Due to non-normal distributions of the continuous variables, differences between them were assessed using non-parametric statistics (for 2—variables, the Mann–Whitney U test was used; for 3 variables or more, the Kruskal–Wallis test was used). Categorical variable differences were assessed using the Fisher exact test for 2 × 2 analyses; Pearson’s χ2 test was used for when the analysis was greater than). A p < 0.05 was the threshold for statistical significance.

3. Results

In this cohort of 190 patients with 223 idiopathic SCFEs, 138 (72.6%) had stable varus SCFEs, 45 (23.6%) unstable varus SCFEs, and 7 (3.7%) valgus SCFEs. All unstable SCFEs were varus, and all valgus SCFEs were stable. Analyses between the three SCFE types (Table 1) demonstrated significant differences between all three groups by age at diagnosis, sex, race, SCFE severity, weight percentile, and duration of symptoms. Children with valgus SCFEs were the youngest and stable varus SCFEs the oldest (Figure 1). The average age for the valgus, unstable, and stable varus groups was 11.0 ± 1.2, 11.8 ± 1.8, and 12.3 ± 1.7 years, respectively (p = 0.019). Patients with valgus SCFEs were mostly female (86%—1 of 7) compared to the stable varus (39.9% 55 of 138) and unstable (47% 21 of 45) groups (p = 0.42). Children with valgus SCFEs were mostly non-White (86%—6 of 7) compared to the stable varus (39.4%—83 of 137) and the unstable (27%—12 of 44) (p = 0.011). SCFE severity was the lowest in the valgus group and highest in the unstable group (Figure 2). The average LESA for the valgus, unstable, and stable varus groups was 25 ± 15, 48 ± 18, and 35 ± 19, respectively (p = 0.0002) Weight percentile was lowest in the valgus group (82nd percentile) with the stable and unstable groups equal at 94th and 95th percentiles, respectively (p = 0.018). The duration of symptoms was less in the unstable group, and relatively equal between the stable varus and valgus groups, and was 2.3 ± 5.0 months in the unstable, 4.1 ± 4.1 months in the valgus, and 4.5 ± 5.0 months in the stable varus groups (p = 0.00005) (Figure 3). There were no differences in the ADI national percentiles between the three groups: 72 ± 20 in the stable varus, 71 ± 22 in the unstable varus, and 63 ± 31 in the stable valgus groups (p = 0.74).
Between the stable and unstable groups, the significant differences in age at diagnosis, SCFE severity, and symptom duration persisted. There were no differences by sex, race, or weight percentile. However, there was a difference in the status of the tri-radiate physis, being closed in 37% (51 of 138 patients) of the stable and 18% (8 of 45 patients) of the unstable SCFE patients (p = 0.018). Between the stable varus and stable valgus groups, the significant differences in age at diagnosis, race, and weight percentile persisted. There were no differences by SCFE severity or duration of symptoms.
Further analyses were performed looking at the status of the tri-radiate physis (open, closing, and closed). This was performed for all 190 patients (Table 2) as well as for the stable SCFE group (Table 3). (Due to the smaller numbers of patients in the unstable and valgus groups, detailed analyses by tri-radiate physis status were not performed.) For the entire cohort, there was a significant difference by age at diagnosis, LESA, symptom duration, and laterality between the three groups. The average age was 11.4 ± 1.6, 12.0 ± 1.5, and 13.3 ± 1.3 years for the open, closing, and closed groups, respectively (p < 10−6). The average LESA was 35 ± 21, 33 ± 18, and 46 ± 17 for the open, closing, and closed groups, respectively (p = 0.0004) (Figure 4). The average duration of symptoms was 1.8 ± 2.4, 2.6 ± 2.4, and 7.7 ± 6.7 for the open, closing, and closed groups, respectively (p < 10−6). The SCFE was more commonly on the right for the closed group (57%) compared to the open (37%) and closing (47%) groups (p = 0.048). When analyzing only the stable SCFE group, the differences remained the same.

4. Discussion

This appears to be the first study comparing the demographics of idiopathic SCFE between all three types—stable varus, unstable, and valgus SCFEs. We noticed several interesting differences involving age at diagnosis, sex, race, SCFE severity, duration of symptoms, and body weight percentiles.
The age at diagnosis was significantly different between all three groups. The median age for the stable group was 12.3 years, 11.7 for the unstable group, and 10.6 for the valgus group. When comparing the literature studies (Table 2), a similar trend was noted for the unstable (12.3 years) and the stable group the oldest (12.8 years). In a meta-analysis of valgus SCFEs [3], the average age was 13.0 years; however, it must be noted that many of those studies were old, and it is known that there has been a gradual decrease in the age of all patients with SCFE over time. When using only studies from 2000 onward, the average age of the valgus groups was 12.2 years (Table 4). Thus, the differences in age at diagnosis between the three groups in our study (valgus youngest, stable oldest) are similar to those in the literature. These differences in age are also reflected in the status of the tri-radiate cartilage, with the unstable group having a higher percentage of patients with open tri-radiate cartilage (64%) compared to the stable varus (41.3%) and valgus (42%) groups.
There was a greater proportion of girls in the valgus group (86%) compared to 40% in the stable varus and 47% in the unstable varus groups. In a recent meta-analysis of 74 patients with valgus SCFEs, 62% were girls. This is much higher than the 35.7% female percentage in SCFE overall [17]. Thus, there clearly is a predilection for valgus SCFEs to be more common in girls. The exact reason for this is unknown, as there is minimal difference between sexes in the neck-shaft angle. Novais et al. [35] studied epiphyseal tilt with computed tomography of adolescents without hip pathology and found that females demonstrated slightly greater anterosuperior epiphyseal tilt (12.9° vs. 10.3°) and trended toward more superior tilt (p = 0.06) when compared to boys. Perhaps this puts the epiphysis in a slightly more valgus position, and when the appropriate stresses are placed on the proximal femur, a valgus SCFE occurs. Regarding the stable varus and unstable groups, there was a slightly higher percentage of girls in the unstable group (47% vs. 40%—p = 0.042). This is in agreement with a literature review where 46% of the unstable and 40% of the stable SCFEs were in girls [13].
Stable valgus SCFEs were much more common in non-White children than stable varus SCFEs (86% vs. 40%—p = 0.021). In an earlier study, spanning 1998 through 2003 from our institution [29], four patients with seven valgus SCFEs were described, and all were Black. In a recent study for Uruguay of eight children with valgus SCFEs [5], seven of the eight were White, and one was Black (Gelink A—personal communication). Segal et al. [4] described patients with valgus SCFE; one was Hispanic, and one was Black. Shank et al. [30] described 12 patients with valgus SCFEs; six were White, and five were Black. Yngve [28] described seven patients with valgus SCFEs; six were Black, and one was White. Koczewski [36] and Kalhor et al. [32] did not mention race in their studies. The racial makeup for these different studies of valgus SCFEs is quite mixed and may or may not represent the racial prevalence from that center or country in which the study originated. These are interesting findings for which we have no explanation, and which will require further study.
Unstable SCFEs had a larger LESA on average, compared to stable varus or valgus SCFEs. The average LESAs for these three groups in our study were 48°, 35°, and 25°, respectively. In a systematic review of 74 patients with valgus SCFEs [3], the average LESA was 23°. Interestingly, the valgus group had a longer duration of symptoms, but a lower LESA. Generally, a longer duration of symptoms is associated with greater LESA [34,37,38]. The average LESA in the literature for stable and unstable SCFE is 29° and 48°, respectively (Table 2), again very similar to our results. Perhaps valgus SCFEs are more stable biomechanically and do not progress as rapidly over time. This might be akin to the concept behind a valgus intertrochanteric osteotomy for the treatment of a femoral neck nonunion or congenital coxa vara.
The average duration of symptoms in patients with SCFE is often several months [13,14,33,39,40,41,42,43,44]. Most studies of SCFE do not differentiate the average duration of symptoms between stable and unstable types. Thus, it is difficult for us to find comparison studies in the literature. We found this surprising, as there are literally hundreds of SCFE papers since the 1993 stable/unstable classification was published, yet there are very few studies differentiating the demographics between the two groups. In this study, the average symptom duration for stable SCFEs was 4.5 months. In an older international study [13], the average duration of symptoms was 4.8 months for chronic SCFEs (which are typically all stable). In a multicenter study of only stable SCFEs [34], the average symptom duration was 5.2 months. In two recent studies, the average symptom duration was 5.2 months [33] and 4.1 months [37]. Both our results and those from the other studies are very similar. Regarding unstable SCFEs, the average symptom duration was less (2.3 months), indicating that there were precedent symptoms before the event leading to the unstable SCFE. This has been previously noted by McPartland et al. [27] in 82 patients with unstable SCFEs; 88% had a history of prior symptoms with an average of 1.4 months. Our 2.3 months is longer than the 1.4 months in the study of McPartland et al. [27], but still with the same conclusion that unstable SCFEs usually have precedent symptoms.
There was an overall difference between the three groups by weight percentiles; however, it was only true between the stable varus and valgus groups (Table 1). The stable varus weight percentile was 95th, the unstable varus 94th, and the valgus group 82nd. A previous study noted that non-obese patients were more likely to present with an unstable SCFE [45] using BMI as the obesity measurement. In our study, we found no difference in the weight percentile between the stable and unstable groups. The Obana study [45] excluded patients if they had no recorded height and weight; the number excluded was not given. This makes comparisons difficult. When reviewing the data from our study where there was a height and thus a BMI, we noted no differences in BMI percentile between the three groups. The patient’s height was not known in all our cases, reflecting our center’s philosophy of intake with any new SCFE patient. When the diagnosis is known ahead of time before an outpatient visit, a height is not obtained as that requires the patient to stand, which is not desired. Thus, our nurses have been instructed to forgo obtaining a height. The emergency department is also a common entry point for SCFE patients, and frequently, the intake personnel do not obtain or record the patient’s height.
It is well known that an open tri-radiate physis indicates a younger patient, and that was confirmed in this study. Information regarding the status of the tri-radiate physis in SCFE patients has been primarily used when considering prophylactic fixation of the opposite hip when a patient with a unilateral SCFE presents. Popejoy et al. [36] were instrumental in pointing this out, and the literature regarding the status of the tri-radiate physis in SCFE patients seems to concentrate solely on the consideration for prophylactic fixation of the opposite hip [46,47,48,49,50,51,52,53,54,55]. Our findings that the status of the tri-radiate physis in SCFE patients is also correlated with SCFE severity (LESA) is likely new and needs further corroboration from other centers.
The strength of this study is that it represents the demographics of SCFE from one tertiary children’s hospital, comparing all three types of idiopathic SCFE, which has not been previously conducted. The discussion above compares either one type from different centers or two types from one center; this study compares all three types from a single center, eliminating the potential bias when comparing different studies. There are certain limitations to this study. The height was only available in 90 of the 138 patients, not allowing us to calculate a BMI in every patient. With retrospective studies, symptom duration is dependent upon patient recall and may not be completely accurate. Racial identification was patient-determined. There were many patients having Hispanic surnames, but they self-registered as White. Thus, some of those in the White group may actually be Hispanic/persons of color and thus not White. Finally, the number of valgus SCFE cases was low, similar to all valgus SCFE studies. However, the non-parametric statistics did demonstrate differences in certain areas (e.g., weight percentile and age), indicating that these differences were real, in spite of the small number of valgus cases.

5. Conclusions

This study has demonstrated that in the three types of idiopathic SCFE, there are differences by age at diagnosis, sex, race, weight percentile, and duration of symptoms. This is baseline data for further studies of children with SCFE, and we encourage researchers in the future to state what type(s) of SCFE is being studied, as there are many differences between these three different types.

Author Contributions

Conceptualization, R.T.L.; methodology, R.T.L., Z.G. and S.S.; formal analysis, R.T.L., Z.G. and S.S.; data curation, R.T.L., Z.G. and S.S.; writing—original draft preparation, R.T.L., Z.G. and S.S.; writing—review and editing, R.T.L., Z.G. and S.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) at Indiana University (protocol code 11060 approved 24 March 2021).

Informed Consent Statement

Patient consent was waived due to our IRB stating it was an exempt study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to the need to access HIPAA-protected medical records.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Loder, R.T.; Greenfield, M.L. Clinical characteristics of children with atypical and idiopathic slipped capital femoral epiphysis: Description of the age-weight test and implications for further diagnostic investigation. J. Pediatr. Orthop. 2001, 21, 481–487. [Google Scholar] [CrossRef]
  2. Whyte, N.; Sullivan, C. Slipped capital femoral epiphysis in atypical patients. Pediatr. Ann. 2016, 45, e128–e134. [Google Scholar] [CrossRef]
  3. Assi, C.; Mansour, J.; Kouyoumdjian, P.; Yammine, K. Valgus slipped capital femoral epiphysis: A systematic review. J. Pediatr. Orthop. B 2021, 30, 116–122. [Google Scholar] [CrossRef] [PubMed]
  4. Segal, L.S.; Weitzel, P.P.; Davidson, R.S. Valgus slipped capital femoral epiphysis: Fact or fiction? Clin. Orthop. 1996, 322, 91–98. [Google Scholar] [CrossRef]
  5. Gelink, A.; Cúneo, A.; Silveri, C.; Tiderius, C.J.; Loder, R.; von Heideken, J. Valgus slipped capital femoral epiphysis: Presentation, treatment, and clinical outcomes using patient-reported measurements. J. Pediatr. Orthop. B 2020, 30, 111–115. [Google Scholar] [CrossRef] [PubMed]
  6. Loder, R.T.; Richards, B.S.; Shapiro, P.S.; Reznick, L.R.; Aronson, D.D. Acute slipped capital femoral epiphysis: The importance of physeal stability. J. Bone Jt. Surg. 1993, 75, 1134–1140. [Google Scholar] [CrossRef]
  7. Perry, D.C.; Metcalfe, D.; Costa, M.L.; Staa, T.V. A nationwide cohort study of slipped capital femoral epiphysis. Arch. Dis. Child. 2017, 102, 1132–1136. [Google Scholar] [CrossRef]
  8. Kelsey, J.L.; Keggi, K.J.; Southwick, W.O. The incidence and distribution of slipped capital femoral epiphysis in Connecticut and southwestern United States. J. Bone Jt. Surg. 1970, 52, 1203–1216. [Google Scholar] [CrossRef]
  9. Lim, Y.-J.; Kagda, F.; Lam, K.S.; Hui, J.H.; Lim, K.B.; Mahadev, A.; Lee, E.H. Demographics and clinical presentation of slipped capital femoral epiphysis in Singapore: Comparing the East with the West. J. Pediatr. Orthop. B 2008, 17, 289–292. [Google Scholar] [CrossRef]
  10. Fedorak, G.T.; Brough, A.K.; Miyamoto, R.H.; Raney, E.M. The epidemiology of slipped capital femoral epiphysis in American Samoa. Hawaii J. Med. Public Health 2018, 77, 215–219. [Google Scholar]
  11. Herngren, B.; Stenmarker, M.; Vavruch, L.; Hagglund, G. Slipped capital femoral epiphysis: A population-based study. BMC Musculoskelet. Disord. 2017, 18, 304. [Google Scholar] [CrossRef] [PubMed]
  12. Jerre, R.; Karlsson, J.; Henrikson, B. The incidence of physiolysis of the hip. A population-based study of 175 patients. Acta Orthop. Scand. 1996, 67, 53–56. [Google Scholar] [CrossRef] [PubMed]
  13. Loder, R.T. Coinvestigators from 33 centers and 6 continents. The demographics of slipped capital femoral epiphysis. An international multicenter study. Clin. Orthop. 1996, 322, 8–27. [Google Scholar] [CrossRef]
  14. Hägglund, G.; Hansson, L.I.; Ordeberg, G. Epidemiology of slipped capital femoral epiphysis in southern Sweden. Clin. Orthop. 1984, 191, 82–94. [Google Scholar] [CrossRef]
  15. Larson, A.N.; Yu, E.M.; Melton, L., III; Peterson, H.A.; Stans, A.A. Incidence of slipped capital femoral epiphysis: A population-based study. J. Pediatr. Orthop. B 2010, 19, 9–12. [Google Scholar] [CrossRef]
  16. Phadnis, J.; Phillps, P.; Willoughby, R. The epidemiologic characteristics of slipped capital femoral epiphysis in Maori children. J. Pediatr. Orthop. 2012, 32, 510–514. [Google Scholar] [CrossRef]
  17. Loder, R.T.; Skopelja, E.N. The epidemiology and demographics of slipped capital femoral epiphysis. ISRN Orthop. 2011, 2011, 486512. [Google Scholar] [CrossRef]
  18. Stott, S.; Bidwell, T. Epidemiology of slipped capital femoral epiphysis in a population with a high proportion of New Zealand Maori and Pacific children. N. Z. Med. J. 2003, 116, U647. [Google Scholar]
  19. Song, K.-S.; Oh, C.-W.; Lee, H.-J.; Kim, S.-D. Society, Multicenter Study Committee of the Korean Pediatric Orthopedic Society. Epidemiology and demographics of slipped capital femoral epiphysis in Korea: A multicenter study by the Korean Pediatric Orthopaedic Society. J. Pediatr. Orthop. 2009, 29, 683–686. [Google Scholar] [CrossRef]
  20. Southwick, W.O. Osteotomy through the lesser trochanter for slipped capital femoral epiphysis. J. Bone Jt. Surg. 1967, 49, 807–835. [Google Scholar] [CrossRef]
  21. Boyer, D.W.; Mickelson, M.R.; Ponseti, I.V. Slipped capital femoral epiphysis. Long-term follow-up of one hundred and twenty-one patients. J. Bone Jt. Surg. 1981, 63, 85–95. [Google Scholar] [CrossRef]
  22. Acheson, R.M. The Oxford method of assessing skeletal maturity. Clin. Orthop. 1957, 10, 19–39. [Google Scholar] [PubMed]
  23. Kalogrianitis, S.; Tan, C.K.; Kemp, G.J.; Bass, A.; Bruce, C. Does unstable slipped capital femoral epiphysis require urgent stabilization? J. Pediatr. Orthop. B 2007, 16, 6–9. [Google Scholar] [CrossRef] [PubMed]
  24. Chen, R.C.; Schoenecker, P.L.; Dobbs, M.B.; Luhmann, S.J.; Szymanski, D.A.; Gordon, J.E. Urgent reduction, fixation, and arthrotomy for unstable slipped capital femoral epiphysis. J. Pediatr. Orthop. 2009, 29, 687–694. [Google Scholar] [CrossRef]
  25. Palocaren, T.; Holmes, L.; Rogers, K.; Kumar, S.J. Outcome of in situ pinning in patients with unstable slipped capital femoral epiphysis: Assessment of risk factors associated with avascular necrosis. J. Pediatr. Orthop. 2010, 30, 31–36. [Google Scholar] [CrossRef] [PubMed]
  26. Alves, C.; Steele, M.; Narayanan, U.; Howard, A.; Alman, B.; Wright, J.G. Open reduction and internal fixation of unstable slipped capital femoral epiphysis by means of surgical dislocation does not decrease the rate of avascular necrosis: A preliminary study. J. Child. Orthop. 2012, 6, 277–283. [Google Scholar] [CrossRef]
  27. McPartland, T.G.; Sankar, W.N.; Kim, Y.-J.; Millis, M.B. Patients with unstable slipped capital femoral epiphysis have antecedent symptoms. Clin. Orthop. 2013, 471, 2132–2136. [Google Scholar] [CrossRef]
  28. Yngve, D.A.; Moulton, D.L.; Evans, E.B. Valgus slipped capital femoral epiphysis. J. Pediatr. Orthop. B 2005, 14, 172–176. [Google Scholar] [CrossRef]
  29. Loder, R.T.; O’Donnell, P.W.; Didelot, W.P.; Kayes, K.J. Valgus slipped capital femoral epiphysis. J. Pediatr. Orthop. 2006, 26, 594–600. [Google Scholar] [CrossRef]
  30. Shank, C.F.; Thiel, E.J.; Klingele, K.E. Valgus slipped capital femoral epiphysis: Prevalence, presentation, and treatment options. J. Pediatr. Orthop. 2010, 30, 140–146. [Google Scholar] [CrossRef]
  31. Koczewski, P. Valgus slipped capital femoral epiphyhsis: Subcapital growth plate orientation analysis. J. Pediatr. Orthop. B 2013, 22, 548–552. [Google Scholar] [CrossRef] [PubMed]
  32. Kalhor, M.; Gharanizadeh, K.; Rego, P.; Leunig, M.; Ganz, R. Valgus slipped capital femoral epiphysis: Pathophysiology of motion and results of intracapsulare realignment. J. Orthop. Trauma 2018, 32S, S5–S11. [Google Scholar] [CrossRef] [PubMed]
  33. Hosseinzadeh, P.; Iwinski, H.J.; Salava, J.; Oeffinger, D. Delay in the diagnosis of stable slipped capital femoral epiphysis. J. Pediatr. Orthop. 2017, 37, e19–e22. [Google Scholar] [CrossRef] [PubMed]
  34. Loder, R.T.; Starnes, T.; Dikos, G.; Aronsson, D.D. Demographic predictors of severity of stable slipped capital femoral epiphyses. J. Bone Jt. Surg. 2006, 88, 97–105. [Google Scholar] [CrossRef]
  35. Novais, E.N.; Maranho, D.A.; Kim, Y.-J.; Kiapour, A. Age- and sex-specific morphologic variations of capital femoral epiphysis growth in children and adolescents without hip disorders. Orthop. J. Sports Med. 2018, 6, 2325967118781579. [Google Scholar] [CrossRef]
  36. Popejoy, D.; Emara, K.; Birch, J. Prediction of contralateral slipped capital femoral epiphsys using the modified Oxford bone age score. J. Pediatr. Orthop. 2012, 32, 290–294. [Google Scholar] [CrossRef]
  37. Schur, M.D.; Andras, L.M.; Broom, A.M.; Barrett, K.K.; Bowman, C.A.; Luther, H.; Goldstein, R.Y.; Fletcher, N.D.; Millis, M.B.; Runner, R.; et al. Continuing delay in the diagnosis of slipped capital femoral epiphysis. J. Pediatr. 2016, 177, 250–254. [Google Scholar] [CrossRef]
  38. Kocher, M.S.; Bishop, J.A.; Weed, B.; Hresko, M.T.; Millis, M.B.; Kim, Y.J.; Kasser, J.R. Delay in diagnosis of slipped capital femoral epiphysis. Pediatrics 2004, 113, e322–e325. [Google Scholar] [CrossRef]
  39. Carney, B.T.; Weinstein, S.W.; Noble, J. Long-term follow-up of slipped capital femoral epiphysis. J. Bone Jt. Surg. 1991, 73, 667–674. [Google Scholar] [CrossRef]
  40. Matava, M.J.; Patton, C.M.; Luhmann, S.; Gordon, J.E.; Schoenecker, P.L. Knee pain as the initial symptom of slipped capital femoral epiphysis: An analysis of initial presentation and treatment. J. Pediatr. Orthop. 1999, 19, 455–460. [Google Scholar] [CrossRef]
  41. Ward, W.T.; Stefko, J.; Wood, K.B.; Stanitski, C.L. Fixation with a single screw for slipped capital femoral epiphysis. J. Bone Jt. Surg. 1992, 74, 799–809. [Google Scholar] [CrossRef]
  42. Aronson, D.D.; Carlson, W.E. Slipped capital femoral epiphysis: A prospective study of fixation with a single screw. J. Bone Jt. Surg. 1992, 74, 810–819. [Google Scholar] [CrossRef]
  43. Aronson, D.D.; Peterson, D.A.; Miller, D.V. Slipped capital femoral epiphysis: The case for internal fixation in situ. Clin. Orthop. 1992, 281, 115–122. [Google Scholar] [CrossRef]
  44. Örtegren, J.; Österman, J.; Tiderius, C.J. Patients’ delay is the major cause for late diagnosis of slipped capital femoral epiphysis. J. Pediatr. Orthop. B 2021, 30, 105–110. [Google Scholar] [CrossRef] [PubMed]
  45. Obana, K.K.; Siddiqui, A.A.; Broom, A.M.; Barrett, K.; Andras, L.M.; Millis, M.B.; Goldstein, R.Y. Slipped capital femoral epiphysis in children without obesity. J. Pediatr. 2020, 218, 192–197. [Google Scholar] [CrossRef] [PubMed]
  46. Danino, B.; Singh, S.; Shi, J.; Yang, J.; Samora, W.P.; Iobst, C.A.; Klingele, K.E. Probability analysis of sequential SCFE (PASS score). J. Child. Orthop. 2020, 14, 387–396. [Google Scholar] [CrossRef]
  47. Donnelly, M.R.; Layne, J.E.; Castañeda, P.G. Surgeon preference for prophylactic contralateral fixation in slipped capital femoral epiphysis (SCFE) patients: A nationwide POSNA study. J. Pediatr. Orthop. 2023, 43, 567–571. [Google Scholar] [CrossRef]
  48. Koenig, K.M.; Thomson, J.D.; Anderson, K.L.; Carney, B.T. Does skeletal maturity predict sequential contralateral involvement after fixation of slipped capital femoral epiphysis? J. Pediatr. Orthop. 2007, 27, 796–800. [Google Scholar] [CrossRef]
  49. Kwiatkowska, M.; Kwiatkowsk, M.; Czubak-Wrzosek, M.; Czubak, J.; Tyrakowski, M. Can we still use X-rays to predict contralateral slip in primary unilateral slipped capital femoral epiphysis? J. Pediatr. Orthop. B 2023, 32, 247–252. [Google Scholar] [CrossRef]
  50. Lindell, M.; Sköldberg, M.; Stenmarker, M.; Michno, P.; Herngren, B. The contralateral hip in slipped capital femoral epiphysis: Is there an easy-to-use algorithm to support a decision for prophylactic fixation? J. Child. Orthop. 2022, 16, 297–305. [Google Scholar] [CrossRef]
  51. Maranho, D.A.; Ferrer, M.G.; Kim, Y.-J.; Miller, P.E.; Novais, E.N. Predicting risk of contralateral slip in unilateral slipped capital femoral epiphysis. Posterior epiphyseal tilt increase and superior epiphyseal extension reduces risk. J. Bone Jt. Surg. 2019, 101, 209–217. [Google Scholar] [CrossRef]
  52. Nowicki, P.D.; Silva, S.; Toelle, L.; Strohmeyer, G.; Mahlquist, T.; Li, Y.; Farley, F.A.; Caird, M.S. Severity of asynchronous slipped capital femoral epiphysis in skeletally immature versus more skeletally mature patients. J. Pediatr. Orthop. 2017, 37, e23–e27. [Google Scholar] [CrossRef] [PubMed]
  53. Puylaert, D.; Dimeglio, A.; Bentahar, T. Staging puberty in slipped capital femoral epiphysis. Importance of the triradiate cartilage. J. Pediatr. Orthop. 2004, 24, 144–147. [Google Scholar] [CrossRef] [PubMed]
  54. Riad, J.; Bajelidze, G.; Gabos, P.G. Bilateral slipped capital femoral epiphysis. Predictive factors for contralateral slip. J. Pediatr. Orthop. 2007, 27, 411–414. [Google Scholar] [CrossRef] [PubMed]
  55. Swarup, I.; Goodbody, C.; Goto, R.; Sankar, W.N.; Fabricant, P.D. Risk factors for contralateral slipped capital femoral epiphysis: A meta-analysis of cohort and case-control studies. J. Pediatr. Orthop. 2020, 40, e446–e453. [Google Scholar] [CrossRef]
Figure 1. Age at diagnosis in years by SCFE type. The black circles represent each patient; the upper and lower boundaries of the boxes represent the upper and lower quartiles, while the bar inside the box is the median. These differences were statistically significant (p = 0.019). STVALG = stable valgus SCFE, STVAR = stable varus SCFE, UNST = unstable varus SCFE.
Figure 1. Age at diagnosis in years by SCFE type. The black circles represent each patient; the upper and lower boundaries of the boxes represent the upper and lower quartiles, while the bar inside the box is the median. These differences were statistically significant (p = 0.019). STVALG = stable valgus SCFE, STVAR = stable varus SCFE, UNST = unstable varus SCFE.
Children 10 01557 g001
Figure 2. SCFE severity using the lateral epiphyseal shaft angle [20]. The black circles represent each patient; the upper and lower boundaries of the boxes represent the upper and lower quartiles, while the bar inside the box is the median. STVALG = stable valgus SCFE, STVAR = stable varus SCFE, UNST = unstable varus SCFE. These differences were statistically significant (p = 0.0002).
Figure 2. SCFE severity using the lateral epiphyseal shaft angle [20]. The black circles represent each patient; the upper and lower boundaries of the boxes represent the upper and lower quartiles, while the bar inside the box is the median. STVALG = stable valgus SCFE, STVAR = stable varus SCFE, UNST = unstable varus SCFE. These differences were statistically significant (p = 0.0002).
Children 10 01557 g002
Figure 3. Symptom duration in months was less in the unstable SCFE group, and relatively equal between the stable varus and valgus groups. The black circles represent each patient; the upper and lower boundaries of the boxes represent the upper and lower quartiles, while the bar inside the box is the median. STVALG = stable valgus SCFE, STVAR = stable varus SCFE, UNST = unstable varus SCFE. These differences were statistically significant (p = 0.002).
Figure 3. Symptom duration in months was less in the unstable SCFE group, and relatively equal between the stable varus and valgus groups. The black circles represent each patient; the upper and lower boundaries of the boxes represent the upper and lower quartiles, while the bar inside the box is the median. STVALG = stable valgus SCFE, STVAR = stable varus SCFE, UNST = unstable varus SCFE. These differences were statistically significant (p = 0.002).
Children 10 01557 g003
Figure 4. SCFE severity using the lateral epiphyseal shaft angle [20]. The circles represent each patient; the upper and lower boundaries of the boxes represent the upper and lower quartiles, while the bar inside the box is the median. N = tri-radiate cartilage not open, P = closing, and Y = open. These differences were statistically significant (p = 0.0004).
Figure 4. SCFE severity using the lateral epiphyseal shaft angle [20]. The circles represent each patient; the upper and lower boundaries of the boxes represent the upper and lower quartiles, while the bar inside the box is the median. N = tri-radiate cartilage not open, P = closing, and Y = open. These differences were statistically significant (p = 0.0004).
Children 10 01557 g004
Table 1. Demographic data by type of SCFE.
Table 1. Demographic data by type of SCFE.
AllStable VarusUnstable VarusStable Valgusp-Value $p-Value *p-Value ^
Continuous variables
All190138457---
LESA (mean ± 1 sd)38 ± 2035 ± 1948 ± 1825 ± 150.00020.00020.17
Age
Mean ± 1 sd12.1 ± 1.712.3 ± 1.711.8 ± 1.811.0 ± 1.20.0190.0480.027
Median (range)12.0
(6.2–17.0)
12.3
(6.8–16.4)
11.7
(6.2–17.0)
10.6
(9.5–13.0)
Weight percentile94 ± 1095 ± 994 ± 982 ± 180.0180.0810.014
Height percentile75 ± 2676 ± 2576 ± 2464 ± 410.840.860.56
BMI percentile93 ± 1593 ± 1690 ± 1194 ± 90.300.120.97
Symptom duration (mos)3.9 ± 5.04.5 ± 5.02.3 ± 5.04.1 ± 4.10.000050.0000090.92
ADI national percentile72 ± 2172 ± 2071 ± 2263 ± 310.740.670.47
Categorical variables
Sex
Female82 (43.2)55 (39.9)21 (47)6 (86)0.050.490.042
Male108 (56.8)83 (60.1)24 (53)1 (14)
Race
Non-white72 (38.3)54 (39.4)12 (27)6 (86)0.0110.160.021
White116 (61.7)83 (60.6)32 (73)1 (14)
Laterality
Left103 (54.2)74 (53.6)25 (56)4 (57)0.960.861.00
Right87 (45.8)64 (46.4)20 (44)3 (43)
Tri-radiate cartilage
Closed61 (32.1)51 (37.0)8 (18)2 (29)0.0820.0180.87
Closing40 (21.1)30 (21.7)8 (18)2 (29)
Open89 (46.8)57 (41.3)29 (64)3 (42)
The numbers in parentheses for the categorical variables are column percentages. $ p value between all three groups, * p value between the stable and unstable groups, ^ p value between the stable varus and stable valgus groups.
Table 2. Status of triradiate cartilage by demographic variables.
Table 2. Status of triradiate cartilage by demographic variables.
OpenClosingClosedp-Value $p-Value *p-Value ^
894061---
LESA (mean ± 1 sd)35 ± 2133 ± 1846 ± 170.00040.740.0007
Age
Mean ± 1 sd11.4 ± 1.612.0 ± 1.513.3 ± 1.3<10−60.069<10−6
Median (range)11.5
(6.2–14.4)
11.8
(8.3–15.0)
13.2
(11.2–17.0)
Weight percentile94 ± 994 ± 1195 ± 110.89--
Height percentile77 ± 2675 ± 2973 ± 250.42--
BMI percentile93 ± 1693 ± 1492 ± 160.73--
Symptom duration (mos)1.8 ± 2.42.6 ± 2.47.7 ± 6.7<10−60.006<10−6
ADI national percentile73 ± 2066 ± 2673 ± 170.47--
Sex
Female34 (38)22 (55)26 (43)0.20--
Male55 (62)18 (45)35 (57)
Race
Non-white29 (33)14 (35)290.19--
White58 (67)26 (65)32
Laterality
Left56 (63)21 (53)26 (43)0.0480.330.019
Right33 (37)19 (47)35 (57)
The numbers in parentheses for the categorical variables are column percentages. $ p value between all three groups, * p value between the open and closing groups, ^ p value between the open and closed groups.
Table 3. Status of triradiate cartilage by demographic variables for the stable SCFE group.
Table 3. Status of triradiate cartilage by demographic variables for the stable SCFE group.
OpenClosingClosedp-Value $p-Value *p-Value ^
573051---
LESA (mean ± 1 sd)28 ± 1928 ± 1646 ± 17<10−60.94<10−6
Age
Mean ± 1 sd11.5 ± 1.612.0 ± 1.613.3 ± 1.3<10−60.620.01
Median (range)11.5
(6.8–14.4)
11.8
(8.3–15.0)
13.3
(11.2–16.4)
Weight percentile96 ± 795 ± 1195 ± 100.91--
Height percentile78 ± 2678 ± 2872 ± 220.15--
BMI percentile93 ± 1794 ± 1593 ± 160.57--
Symptom duration (mos)2.3 ± 2.82.8 ± 2.67.8 ± 6.1<10−60.76<10−6
ADI national percentile74 ± 2069 ± 2473 ± 160.83--
Sex
Female18 (32)17 (57)29 (48)0.075--
Male39 (68)13 (43)31 (52)
Race
Non-white19 (37)10 (33)25 (49)0.21--
White37 (63)20 (67)26 (51)
Laterality
Left38 (67)14 (47)22 (43)0.0340.330.019
Right19 (33)16 (53)29 (57)
The numbers in parentheses for the categorical variables are column percentages. $ p value between all three groups, * p value between the open and closing groups, ^ p value between the open and closed groups.
Table 4. Synopsis of the literature.
Table 4. Synopsis of the literature.
AuthorYearOverall Number in the StudyNumber of Appropriate Patients within the Subgroup &Average Age (Years)Average LESA *Symptom Duration (Months)BoysGirls%Girls
Unstable SCFEs
Loder [6]1993NA301251NA141653.3
Kalogrianitis [23]2007821612.3NANA9743.8
Chen [24]2009NA2311.9NA1.016730.4
Palocaren [25]20102802712.251NA19829.6
Alves [26]20121891212.233NA6650.0
McPartland [27]20135828212.5NA1.4414150.0
Weighted average 113319012.348 1058544.7
Valgus SCFEs
Yngve [28]2005NA714.134NA3457.1
Loder [29]2006105411.71413.02250.0
Shank [30]20102581211.6301.85758.3
Koczewski [31]20131151111.1232.75654.5
Kalhor [32]2018NA613.821NA3350.0
Gelink [5]2020NA811.928 2675.0
Weighted average 4812.226 202858.3
Loder [13]19961630136312.9NA4.881255140.4
Stable SCFEs
Hosseinzadeh [33]2017NA14911.8NA5.2896040.3
Loder ^ [34]2006NA24312.6295.21598434.6
Weighted average 12.829 106069539.6
* LESA = the lateral epiphyseal shaft angle of Southwick [20]; ^ using the older terminology of chronic, which is in all likelihood stable; & denotes the number of cases in the study that fit the SCFE type; NA means the data was not available.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Loder, R.T.; Gunderson, Z.; Sun, S. Idiopathic Slipped Capital Femoral Epiphysis: Demographic Differences and Similarities between Stable, Unstable, and Valgus Types. Children 2023, 10, 1557. https://doi.org/10.3390/children10091557

AMA Style

Loder RT, Gunderson Z, Sun S. Idiopathic Slipped Capital Femoral Epiphysis: Demographic Differences and Similarities between Stable, Unstable, and Valgus Types. Children. 2023; 10(9):1557. https://doi.org/10.3390/children10091557

Chicago/Turabian Style

Loder, Randall T., Zachary Gunderson, and Seungyup Sun. 2023. "Idiopathic Slipped Capital Femoral Epiphysis: Demographic Differences and Similarities between Stable, Unstable, and Valgus Types" Children 10, no. 9: 1557. https://doi.org/10.3390/children10091557

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop